Patent details

EP1786902 Title: A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES

Basic Information

Publication number:
EP1786902
PCT Application Number:
PCT/US/2005/025831
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057909178
PCT Publication Number:
WO/2006/031291
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES
French Title of Invention:
NOUVELLE CLASSE DE MOLECULES A BASE DE PROTEINES THERAPEUTIQUES
German Title of Invention:
NEUE KLASSE THERAPEUTISCHER MOLEKÜLE AUF PROTEINBASIS
SPC Number:

Dates

Filing date:
21/07/2005
Grant date:
09/09/2015
EP Publication Date:
09/09/2015
PCT Publication Date:
23/03/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/05/2007
EP B1 Publication Date:
09/09/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/07/2016
Expiration date:
21/07/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/03/2016
 
 

Name:
Ansun Biopharma Inc.
Address:
3030 Callan Road, San Diego CA 92121, United States (US)

Inventor

1

Name:
MALAKHOV Michael
Address:
United States (US)

2

Name:
FANG Fang
Address:
United States (US)

Priority

Priority Number:
939262
Priority Date:
10/09/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages